Sermonix Pharmaceuticals
PrivateLast Round
Strategic
Dec 18, 2023
Total Funding Raised
$107.1M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Sermonix Pharmaceuticals operates in Healthcare & Life Sciences and is based in Columbus, Ohio. Its latest recorded funding round was a Strategic round in December 2023.
Sermonix Pharmaceuticals is a biotechnology company that develops and commercializes female-specific oncology products, with a focus on treating ESR1-mutated metastatic breast and gynecological cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sermonix Pharmaceuticals Comparables
Compare Sermonix Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Olema Oncology | 80% | |
| Arvinas Inc | 80% | |
| Kind Pharmaceutical | 80% |
For institutional investors. Book with your work email.
Sermonix Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Dec 18, 2023 | ||||
| Series A Extension | Nov 15, 2021 | ||||
| Series A | Jul 31, 2019 | ||||
| Seed | Oct 31, 2017 | ||||
| Seed | Nov 10, 2016 |
For institutional investors. Book with your work email.
Sermonix Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Perceptive Advisors | Series A Extension |
| Xontogeny | Series A Extension |
| WILD Family Office | Series A |
| HP WILD HOLDING AG | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 38% MoM.
- Dec 18, 2025
Global rights for certain assets acquired by Athira Pharma.
For institutional investors. Book with your work email.
Sermonix Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Sermonix Pharmaceuticals's valuation, stock price, and market status.
Is Sermonix Pharmaceuticals a public or private company?
Sermonix Pharmaceuticals is a private company.
What is the current stock price of Sermonix Pharmaceuticals?
Sermonix Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Sermonix Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Sermonix Pharmaceuticals worth (valuation)?
Valuation information for Sermonix Pharmaceuticals is not publicly available.
Can I buy Sermonix Pharmaceuticals stock?
Sermonix Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Sermonix Pharmaceuticals's last funding round?
Sermonix Pharmaceuticals's most recent funding round was Strategic on December 18, 2023.
Who are the main investors in Sermonix Pharmaceuticals?
Key investors in Sermonix Pharmaceuticals include Perceptive Advisors, Xontogeny, WILD Family Office, HP WILD HOLDING AG.
Will Sermonix Pharmaceuticals IPO soon?
No public IPO plans have been announced for Sermonix Pharmaceuticals.
How can I track Sermonix Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in Sermonix Pharmaceuticals's shares on secondary markets.